The Patent Finder
CB

Cathay Biotech Inc.

First filing 2013
OverviewNotableFeesChangesFamiliesPatent listSources & methods

49 patents currently held

3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Mar 2032. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2032
Next term end
24
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Mar 3 to 12, 2027 · next Mar 3
  • 1 fee due Apr 10, 2027
    The maintenance fee for Reducing the Accumulation of Imines/Enamines for the Production of Amino Acids or Amino Acid-Derived Products (US 11,781,163) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
  • 3 fees due May 5 to 26, 2027 · next May 5
  • 1 fee due Jun 10, 2027
    The maintenance fee for Modified Membrane Permeability (US 10,501,503) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
  • 2 fees due Jul 12 to 21, 2027 · next Jul 12
  • 1 fee due Sep 10, 2027
    The maintenance fee for Expression of Klebsiella Oxytoca Polypeptides Involved in Lysine Decarboxylation, and Methods and Applications Thereof (US 10,584,149) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
  • 2 fees due Oct 7 to 14, 2027 · next Oct 7
  • 1 fee due Nov 12, 2027
    The maintenance fee for Expression of Polypeptides Involved in Lysine Decarboxylation, and Methods and Applications Thereof (US 10,647,976) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 24 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 9,388,378Candida Sake Strain for Producing Long Chain Dicarboxylic Acids
In force
 · High confidence
In forceHigh confidence
US 9,650,326Process for Treating Reaction Solution Containing Long Chain Dicarboxylate
In force
 · High confidence
In forceHigh confidence
US 9,546,127Purification of Cadaverine
In force
 · High confidence
In forceHigh confidence
US 9,556,106Purification of Cadaverine Using High Boiling Point Solvent
In force
 · High confidence
In forceHigh confidence
US 9,896,409Purification of Cadaverine Using High Boiling Point Solvent
In force
 · High confidence
In forceHigh confidence
US 9,914,694Purification of Cadaverine Using High Boiling Point Solvent
In force
 · High confidence
In forceHigh confidence
US 9,919,996Preparation of Cadaverine
In force
 · High confidence
In forceHigh confidence
US 10,464,880Purification of Cadaverine Using High Boiling Point Solvent
In force
 · Medium confidence
In forceMedium confidence
US 9,234,203Stabilized Recombinant Expression Plasmid Vector in Hafnia Alvei and Applications Thereof
In force
 · High confidence
In forceHigh confidence
US 10,221,407Stabilized Recombinant Expression Plasmid Vector in Hafnia Alvei and Applications Thereof
In force
 · Low confidence
In forceLow confidence
10 of 49 patents shown.
Pro members see all 49.
Pro members: see all 49 patents
Also on record, not counted in the 49: 3 patents in force now held by others · 15 applications pending · 3 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited